Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Learn how to plan for success using zero based budgeting to achieve your financial goals. Start your journey to success today.
19,670 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
As Haverty prepares for its 2025 earnings release, investors seek clarity on margins, store performance, and forward ...
In the wake of a Supreme Court ruling voiding emergency tariffs, Trump warns trading partners they could face far har...
As markets swing in early 2026, the most powerful wealth builders are those who do less, not more. A growing body of ...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
A wave of institutional interest is reshaping AI infrastructure stocks. This guide explains why capital is flowing in...
A Capitol Hill probe into Epstein-era ties turned volatile this week, with lawmakers veering from policy questions to...
As NVIDIA readies its GTC keynote, memory names MU and SNDK swing on speculation about a new inference chip that coul...
SpaceX is lining up a blockbuster IPO that could outpace the entire 2025 IPO slate. Analysts estimate a multi-billion...
Lucid has set a production target, but many investors wonder if the pace will match the plan. This deep dive explains...
Three AI infrastructure names join the S&P 500 in a quarterly rebalance, signaling AI hardware is moving from specula...